Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2005 2
2006 1
2007 1
2009 3
2010 3
2011 3
2012 1
2013 4
2014 3
2015 2
2017 5
2018 6
2019 9
2020 7
2021 8
2022 12
2023 7
2024 11
2025 5

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

83 results

Results by year

Filters applied: . Clear all
Page 1
New-Onset Diabetes after Kidney Transplantation.
Ponticelli C, Favi E, Ferraresso M. Ponticelli C, et al. Among authors: favi e. Medicina (Kaunas). 2021 Mar 8;57(3):250. doi: 10.3390/medicina57030250. Medicina (Kaunas). 2021. PMID: 33800138 Free PMC article. Review.
Allograft Vesicoureteral Reflux after Kidney Transplantation.
Brescacin A, Iesari S, Guzzo S, Alfieri CM, Darisi R, Perego M, Puliatti C, Ferraresso M, Favi E. Brescacin A, et al. Among authors: favi e. Medicina (Kaunas). 2022 Jan 5;58(1):81. doi: 10.3390/medicina58010081. Medicina (Kaunas). 2022. PMID: 35056389 Free PMC article. Review.
Advancing immunosuppression in liver transplantation: A narrative review.
Iesari S, Nava FL, Zais IE, Coubeau L, Ferraresso M, Favi E, Lerut J. Iesari S, et al. Among authors: favi e. Hepatobiliary Pancreat Dis Int. 2024 Oct;23(5):441-448. doi: 10.1016/j.hbpd.2024.03.001. Epub 2024 Mar 16. Hepatobiliary Pancreat Dis Int. 2024. PMID: 38523030 Review.
Sequential administration of anti-complement component C5 eculizumab and type-2 anti-CD20 obinutuzumab for the treatment of early antibody-mediated rejection after kidney transplantation: A proof of concept.
Favi E, Cresseri D, Perego M, Ikehata M, Iesari S, Campise MR, Morello W, Testa S, Sioli V, Mattinzoli D, Longhi E, Del Gobbo A, Castellano G, Ferraresso M. Favi E, et al. Clin Immunol. 2024 Jul;264:110240. doi: 10.1016/j.clim.2024.110240. Epub 2024 May 9. Clin Immunol. 2024. PMID: 38734036 Free article.
83 results